Patent details

300191 Product Name: Darifenacine, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout, in het bijzonder het hydrobromide

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300191
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP0388054
Status:
Expired Art. 14 (a) of the EC Regulations
Application number:
300191
Procedural language:
Dutch
First Applicant Residence Country:

Marketing Authorization

1

Marketing Authorization Number:
EU1/04/294/001
Marketing Authorization Type:
EEA
Marketing Authorization Date:
22/10/2004
Marketing Authorization Country:
European Union (EU)

2

Marketing Authorization Number:
EU1/04/294/002
Marketing Authorization Type:
EEA
Marketing Authorization Date:
22/10/2004
Marketing Authorization Country:
European Union (EU)

3

Marketing Authorization Number:
EU1/04/294/003
Marketing Authorization Type:
EEA
Marketing Authorization Date:
22/10/2004
Marketing Authorization Country:
European Union (EU)

4

Marketing Authorization Number:
EU1/04/294/004
Marketing Authorization Type:
EEA
Marketing Authorization Date:
22/10/2004
Marketing Authorization Country:
European Union (EU)

5

Marketing Authorization Number:
EU1/04/294/005
Marketing Authorization Type:
EEA
Marketing Authorization Date:
22/10/2004
Marketing Authorization Country:
European Union (EU)

6

Marketing Authorization Number:
EU1/04/294/006
Marketing Authorization Type:
EEA
Marketing Authorization Date:
22/10/2004
Marketing Authorization Country:
European Union (EU)

7

Marketing Authorization Number:
EU1/04/294/007
Marketing Authorization Type:
EEA
Marketing Authorization Date:
22/10/2004
Marketing Authorization Country:
European Union (EU)

8

Marketing Authorization Number:
EU1/04/294/008
Marketing Authorization Type:
EEA
Marketing Authorization Date:
22/10/2004
Marketing Authorization Country:
European Union (EU)

9

Marketing Authorization Number:
EU1/04/294/009
Marketing Authorization Type:
EEA
Marketing Authorization Date:
22/10/2004
Marketing Authorization Country:
European Union (EU)

10

Marketing Authorization Number:
EU1/04/294/0012
Marketing Authorization Type:
EEA
Marketing Authorization Date:
22/10/2004
Marketing Authorization Country:
European Union (EU)

11

Marketing Authorization Number:
EU1/04/294/0010
Marketing Authorization Type:
EEA
Marketing Authorization Date:
22/10/2004
Marketing Authorization Country:
European Union (EU)

12

Marketing Authorization Number:
EU1/04/294/0011
Marketing Authorization Type:
EEA
Marketing Authorization Date:
22/10/2004
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
08/04/2005
First Marketing Authorization date:
22/10/2004
Grant date:
06/06/2005
Activation date:
02/03/2010
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
08/04/2005
SPC/SPC Extension Expiration Date:
01/03/2015
Lapsed By Expiration Date:
02/03/2015
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
06/05/2013
 
 

 

Name:
Merus Labs Luxco SARL
Address:
208 Val des Bons Malades, 2121, Luxemburg, Luxembourg (LU)

Historical Applicant/holder

From:
08/04/2005
To:
06/05/2013

 

Name:
Novartis International Pharmaceutical Ltd.
Address:
131 Front Street, HM 12, Hamilton, Bermuda (BM)

Agent

Name:
ir. F.A. Geurts c.s.
From:
08/04/2005
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
2015/11
Publication date:
11/03/2015
Description:
Lapse or annulment

2

Bulletin Heading:
MED
Journal edition number:
2015/05
Publication date:
28/01/2015
Description:
Other communications

3

Bulletin Heading:
MED
Journal edition number:
2015/05
Publication date:
28/01/2015
Description:
Other communications

4

Bulletin Heading:
MED
Journal edition number:
2014/24
Publication date:
11/06/2014
Description:
Other communications

5

Bulletin Heading:
CO
Journal edition number:
2013/25
Publication date:
19/06/2013
Description:
Changes in the Netherlands Patent Register

6

Bulletin Heading:
SPC
Journal edition number:
2005/08
Publication date:
01/08/2005
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

7

Bulletin Heading:
SPC
Journal edition number:
2005/07
Publication date:
01/07/2005
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Deed

Right of Pledge

Change Kind/ Decision Type:
Removed
Deed Number:
022891-A022891-1
Date Registered:
22/12/2014
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Indiening opheffing pandrecht op 22 december 2014 door Vriesendorp & Gaade te Den Haag. Opheffing van pandrecht met aktenummer 022046. Pandgever was Merus Labs Luxco SARL te Luxemburg, Luxemburg Pandhouder was Royal Bank of Canada te Richmond Hill, Ontario, Canada Zie verder de akte.
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Right of Pledge

Change Kind/ Decision Type:
Established
Deed Number:
022892-A022892-1
Date Registered:
22/12/2014
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Indiening pandakte op 22 december 2014 door Vriesendorp & Gaade te Den Haag. Pandgever is Merus Labs Luxco SARL te Luxemburg, Luxemburg. Pandhouder is Bank of Montreal te Toronto, Ontario, Canada. Zie verder de akte.
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Right of Pledge

Change Kind/ Decision Type:
Established
Deed Number:
022046-A022046-1
Date Registered:
02/06/2014
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Indiening pandakte op 2 juni 2014 door Vriesendorp & Gaade te Den Haag. Pandgever is Merus Labs Luxco SARL te Luxemburg in Luxemburg. Pandhouder is Royal Bank of Canada te Richmond Hill, Ontario in de USA. Zie verder de akte.
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
019666-A019666-1
Date Registered:
06/05/2013
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
27/03/2014
Last Annual Fee Paid Number:
25
Last Annual Fee Paid Amount:
2400 Euro
Payer:
Arnold & Siedsma BV
Filing date Document type Document Description Number of pages File Type
06/06/2005 Outgoing Correspondence Outgoing Letter 1 PDF /1/9/1/0/0/0400300191/docs/300191_0_outgoingcorrespondence20050606.pdf
06/06/2005 Outgoing Correspondence Outgoing Letter 1 PDF /1/9/1/0/0/0400300191/docs/300191_2_outgoingcorrespondence20050606.pdf
19/04/2005 Incoming Correspondence Paper Other 1 PDF /1/9/1/0/0/0400300191/docs/300191_1_incomingcorrespondencepaper20050419.pdf
08/04/2005 Application Form First filed application form 2 PDF /1/9/1/0/0/0400300191/docs/300191_3_applicationform20050408.pdf
08/04/2005 General 4 PDF /1/9/1/0/0/0400300191/docs/300191_4_spc-documents20050408.pdf
08/04/2005 Incoming Correspondence Paper Other 1 PDF /1/9/1/0/0/0400300191/docs/300191_5_incomingcorrespondencepaper20050408.pdf
08/04/2005 General 19 PDF /1/9/1/0/0/0400300191/docs/300191_6_spc-documents20050408.pdf